A peptide derived from DEPDC1 611‐628 amino acid residues (named as 11R‐DEP:611‐628) can disrupt DEPDC1/ZNF224 complex and thus may inhibit cell proliferation of bladder cancer.11 Here, DEPDC1 is linked to urinary bladder cancer.